ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

ClinicalTrials.gov ID: NCT05567796

Public ClinicalTrials.gov record NCT05567796. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Cagrilintide s.c. 2.4 Milligram (mg) in Combination With Semaglutide Subcutaneous (s.c). 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity

Study identification

NCT ID
NCT05567796
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
3,400 participants

Conditions and interventions

Conditions

Interventions

  • Cagrilintide Drug
  • Placebo cagrilintide Drug
  • Placebo semaglutide Drug
  • Semaglutide Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2022
Primary completion
Oct 29, 2024
Completion
Oct 18, 2026
Last update posted
May 4, 2026

2022 – 2026

United States locations

U.S. sites
45
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Univ of Alabama Birmingham Birmingham Alabama 35233
Velocity Clin Res Los Angeles Los Angeles California 90017
Velocity Clin Res Wstlke Los Angeles California 90057
Univ of Colorado at Denver Aurora Colorado 80045
OptumCare Clinical Trials LLC Golden Colorado 80401
Northeast Research Institute Fleming Island Florida 92003
South Broward Research LLC Miramar Florida 33027
Clinical Neuroscience Solution Orlando Florida 32801
Florida Inst For Clin Res Orlando Florida 32825
Clinical Trial Res Assoc,Inc Plantation Florida 33324
Hope Clin Res & Wellness Conyers Georgia 30094
East West Med Res Inst Honolulu Hawaii 96814
Great Lakes Clinical Trials Chicago Illinois 60640
Endeavor Health Skokie Illinois 60077
Evanston Premier Hlthcr Res Skokie Illinois 60077
Midwest Inst For Clin Res Indianapolis Indiana 46260
Northern Pines Hlth Ctr, PC Buckley Michigan 49620
StudyMetrix Research LLC City of Saint Peters Missouri 63303
Velocity Clinical Research Binghamton Binghamton New York 13905
Comprehensive Weight Ctrl Prog New York New York 10021
University of North Carolina Chapel Hill North Carolina 27514
University of North Carolina Chapel Hill North Carolina 27517
Medication Mgmnt, LLC_Grnsboro Greensboro North Carolina 27405
PharmQuest Life Sciences LLC Greensboro North Carolina 27408
Accellacare_NC Raleigh North Carolina 27609
Accellacare Wilmington North Carolina 28401
New Venture Medical Research Wadsworth Ohio 44281
Lynn Institute of Norman Norman Oklahoma 73072
The University of Penn Center Philadelphia Pennsylvania 19104-3317
Clinical Res Collaborative Cumberland Rhode Island 02864
Medical Uni of SC Charleston Charleston South Carolina 29425
Coastal Carolina Res Ctr North Charleston South Carolina 29405
Hillcrest Clinical Research Simpsonville South Carolina 29681-1538
Spartanburg Medical Research Spartanburg South Carolina 29303
Holston Medical Group_Bristol Bristol Tennessee 37620
Holston Medical Group Kingsport Tennessee 37660
Baylr Sctt White Rs Inst, Endo Dallas Texas 75226
Velocity Clinical Res-Dallas Dallas Texas 75230
UT Southwestern Med Cntr Dallas Texas 75390-9302
DCOL Ctr for Clin Res Longview Texas 75605
Washington Cntr Weight Mgmt Arlington Virginia 22206
Health Res of Hampton Roads Newport News Virginia 23606
Selma Medical Associates Winchester Virginia 22601-3834
Capital Clin Res Ctr,LLC Olympia Washington 98502
Rainier Clin Res Ctr Inc Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 209 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05567796, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05567796 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →